table of content
1 Introduction to Research & Analysis Reports
1.1 Immuno-oncology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immuno-oncology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immuno-oncology Drugs Overall Market Size
2.1 Global Immuno-oncology Drugs Market Size: 2022 VS 2029
2.2 Global Immuno-oncology Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Immuno-oncology Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Immuno-oncology Drugs Players in Global Market
3.2 Top Global Immuno-oncology Drugs Companies Ranked by Revenue
3.3 Global Immuno-oncology Drugs Revenue by Companies
3.4 Global Immuno-oncology Drugs Sales by Companies
3.5 Global Immuno-oncology Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Immuno-oncology Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Immuno-oncology Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immuno-oncology Drugs Players in Global Market
3.8.1 List of Global Tier 1 Immuno-oncology Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Immuno-oncology Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Immuno-oncology Drugs Market Size Markets, 2022 & 2029
4.1.2 Immune Checkpoint Inhibitors
4.1.3 Immune System Modulators
4.1.4 Cancer Vaccines
4.1.5 Oncolytic Virus
4.1.6 Others
4.2 By Type - Global Immuno-oncology Drugs Revenue & Forecasts
4.2.1 By Type - Global Immuno-oncology Drugs Revenue, 2018-2023
4.2.2 By Type - Global Immuno-oncology Drugs Revenue, 2024-2029
4.2.3 By Type - Global Immuno-oncology Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Immuno-oncology Drugs Sales & Forecasts
4.3.1 By Type - Global Immuno-oncology Drugs Sales, 2018-2023
4.3.2 By Type - Global Immuno-oncology Drugs Sales, 2024-2029
4.3.3 By Type - Global Immuno-oncology Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Immuno-oncology Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immuno-oncology Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.2 By Application - Global Immuno-oncology Drugs Revenue & Forecasts
5.2.1 By Application - Global Immuno-oncology Drugs Revenue, 2018-2023
5.2.2 By Application - Global Immuno-oncology Drugs Revenue, 2024-2029
5.2.3 By Application - Global Immuno-oncology Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Immuno-oncology Drugs Sales & Forecasts
5.3.1 By Application - Global Immuno-oncology Drugs Sales, 2018-2023
5.3.2 By Application - Global Immuno-oncology Drugs Sales, 2024-2029
5.3.3 By Application - Global Immuno-oncology Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Immuno-oncology Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Immuno-oncology Drugs Market Size, 2022 & 2029
6.2 By Region - Global Immuno-oncology Drugs Revenue & Forecasts
6.2.1 By Region - Global Immuno-oncology Drugs Revenue, 2018-2023
6.2.2 By Region - Global Immuno-oncology Drugs Revenue, 2024-2029
6.2.3 By Region - Global Immuno-oncology Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Immuno-oncology Drugs Sales & Forecasts
6.3.1 By Region - Global Immuno-oncology Drugs Sales, 2018-2023
6.3.2 By Region - Global Immuno-oncology Drugs Sales, 2024-2029
6.3.3 By Region - Global Immuno-oncology Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Immuno-oncology Drugs Revenue, 2018-2029
6.4.2 By Country - North America Immuno-oncology Drugs Sales, 2018-2029
6.4.3 US Immuno-oncology Drugs Market Size, 2018-2029
6.4.4 Canada Immuno-oncology Drugs Market Size, 2018-2029
6.4.5 Mexico Immuno-oncology Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Immuno-oncology Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Immuno-oncology Drugs Sales, 2018-2029
6.5.3 Germany Immuno-oncology Drugs Market Size, 2018-2029
6.5.4 France Immuno-oncology Drugs Market Size, 2018-2029
6.5.5 U.K. Immuno-oncology Drugs Market Size, 2018-2029
6.5.6 Italy Immuno-oncology Drugs Market Size, 2018-2029
6.5.7 Russia Immuno-oncology Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Immuno-oncology Drugs Market Size, 2018-2029
6.5.9 Benelux Immuno-oncology Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Immuno-oncology Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Immuno-oncology Drugs Sales, 2018-2029
6.6.3 China Immuno-oncology Drugs Market Size, 2018-2029
6.6.4 Japan Immuno-oncology Drugs Market Size, 2018-2029
6.6.5 South Korea Immuno-oncology Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Immuno-oncology Drugs Market Size, 2018-2029
6.6.7 India Immuno-oncology Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Immuno-oncology Drugs Revenue, 2018-2029
6.7.2 By Country - South America Immuno-oncology Drugs Sales, 2018-2029
6.7.3 Brazil Immuno-oncology Drugs Market Size, 2018-2029
6.7.4 Argentina Immuno-oncology Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Immuno-oncology Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Immuno-oncology Drugs Sales, 2018-2029
6.8.3 Turkey Immuno-oncology Drugs Market Size, 2018-2029
6.8.4 Israel Immuno-oncology Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Immuno-oncology Drugs Market Size, 2018-2029
6.8.6 UAE Immuno-oncology Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen, Inc
7.1.1 Amgen, Inc Company Summary
7.1.2 Amgen, Inc Business Overview
7.1.3 Amgen, Inc Immuno-oncology Drugs Major Product Offerings
7.1.4 Amgen, Inc Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Amgen, Inc Key News & Latest Developments
7.2 AstraZeneca, Plc
7.2.1 AstraZeneca, Plc Company Summary
7.2.2 AstraZeneca, Plc Business Overview
7.2.3 AstraZeneca, Plc Immuno-oncology Drugs Major Product Offerings
7.2.4 AstraZeneca, Plc Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca, Plc Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Major Product Offerings
7.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Celgene Corporation
7.4.1 Celgene Corporation Company Summary
7.4.2 Celgene Corporation Business Overview
7.4.3 Celgene Corporation Immuno-oncology Drugs Major Product Offerings
7.4.4 Celgene Corporation Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Celgene Corporation Key News & Latest Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Immuno-oncology Drugs Major Product Offerings
7.5.4 Eli Lilly and Company Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly and Company Key News & Latest Developments
7.6 Merck & Co.
7.6.1 Merck & Co. Company Summary
7.6.2 Merck & Co. Business Overview
7.6.3 Merck & Co. Immuno-oncology Drugs Major Product Offerings
7.6.4 Merck & Co. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Merck & Co. Key News & Latest Developments
7.7 Hoffmann-La Roche AG
7.7.1 Hoffmann-La Roche AG Company Summary
7.7.2 Hoffmann-La Roche AG Business Overview
7.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Major Product Offerings
7.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Hoffmann-La Roche AG Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Immuno-oncology Drugs Major Product Offerings
7.8.4 Johnson & Johnson Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Novartis International AG
7.9.1 Novartis International AG Company Summary
7.9.2 Novartis International AG Business Overview
7.9.3 Novartis International AG Immuno-oncology Drugs Major Product Offerings
7.9.4 Novartis International AG Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Novartis International AG Key News & Latest Developments
7.10 AbbVie, Inc.
7.10.1 AbbVie, Inc. Company Summary
7.10.2 AbbVie, Inc. Business Overview
7.10.3 AbbVie, Inc. Immuno-oncology Drugs Major Product Offerings
7.10.4 AbbVie, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.10.5 AbbVie, Inc. Key News & Latest Developments
7.11 Pfizer Inc.
7.11.1 Pfizer Inc. Company Summary
7.11.2 Pfizer Inc. Immuno-oncology Drugs Business Overview
7.11.3 Pfizer Inc. Immuno-oncology Drugs Major Product Offerings
7.11.4 Pfizer Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Pfizer Inc. Key News & Latest Developments
7.12 Sanofi S.A.
7.12.1 Sanofi S.A. Company Summary
7.12.2 Sanofi S.A. Immuno-oncology Drugs Business Overview
7.12.3 Sanofi S.A. Immuno-oncology Drugs Major Product Offerings
7.12.4 Sanofi S.A. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Sanofi S.A. Key News & Latest Developments
7.13 EMD Serono, Inc.
7.13.1 EMD Serono, Inc. Company Summary
7.13.2 EMD Serono, Inc. Immuno-oncology Drugs Business Overview
7.13.3 EMD Serono, Inc. Immuno-oncology Drugs Major Product Offerings
7.13.4 EMD Serono, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.13.5 EMD Serono, Inc. Key News & Latest Developments
7.14 Gilead Sciences Inc.
7.14.1 Gilead Sciences Inc. Company Summary
7.14.2 Gilead Sciences Inc. Business Overview
7.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Major Product Offerings
7.14.4 Gilead Sciences Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Gilead Sciences Inc. Key News & Latest Developments
7.15 Prometheus Therapeutics & Diagnostics
7.15.1 Prometheus Therapeutics & Diagnostics Company Summary
7.15.2 Prometheus Therapeutics & Diagnostics Business Overview
7.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Major Product Offerings
7.15.4 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Prometheus Therapeutics & Diagnostics Key News & Latest Developments
7.16 Aduro BioTech
7.16.1 Aduro BioTech Company Summary
7.16.2 Aduro BioTech Business Overview
7.16.3 Aduro BioTech Immuno-oncology Drugs Major Product Offerings
7.16.4 Aduro BioTech Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Aduro BioTech Key News & Latest Developments
7.17 Galena Biopharma
7.17.1 Galena Biopharma Company Summary
7.17.2 Galena Biopharma Business Overview
7.17.3 Galena Biopharma Immuno-oncology Drugs Major Product Offerings
7.17.4 Galena Biopharma Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Galena Biopharma Key News & Latest Developments
7.18 Bavarian Nordic
7.18.1 Bavarian Nordic Company Summary
7.18.2 Bavarian Nordic Business Overview
7.18.3 Bavarian Nordic Immuno-oncology Drugs Major Product Offerings
7.18.4 Bavarian Nordic Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Bavarian Nordic Key News & Latest Developments
7.19 Celldex Therapeutics
7.19.1 Celldex Therapeutics Company Summary
7.19.2 Celldex Therapeutics Business Overview
7.19.3 Celldex Therapeutics Immuno-oncology Drugs Major Product Offerings
7.19.4 Celldex Therapeutics Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Celldex Therapeutics Key News & Latest Developments
7.20 ImmunoCellular Therapeutics
7.20.1 ImmunoCellular Therapeutics Company Summary
7.20.2 ImmunoCellular Therapeutics Business Overview
7.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Major Product Offerings
7.20.4 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.20.5 ImmunoCellular Therapeutics Key News & Latest Developments
7.21 Incyte
7.21.1 Incyte Company Summary
7.21.2 Incyte Business Overview
7.21.3 Incyte Immuno-oncology Drugs Major Product Offerings
7.21.4 Incyte Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Incyte Key News & Latest Developments
7.22 Dendreon Corporation
7.22.1 Dendreon Corporation Company Summary
7.22.2 Dendreon Corporation Business Overview
7.22.3 Dendreon Corporation Immuno-oncology Drugs Major Product Offerings
7.22.4 Dendreon Corporation Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.22.5 Dendreon Corporation Key News & Latest Developments
7.23 Agilent Technologies Inc.
7.23.1 Agilent Technologies Inc. Company Summary
7.23.2 Agilent Technologies Inc. Business Overview
7.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Major Product Offerings
7.23.4 Agilent Technologies Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.23.5 Agilent Technologies Inc. Key News & Latest Developments
7.24 Agenus Inc.
7.24.1 Agenus Inc. Company Summary
7.24.2 Agenus Inc. Business Overview
7.24.3 Agenus Inc. Immuno-oncology Drugs Major Product Offerings
7.24.4 Agenus Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.24.5 Agenus Inc. Key News & Latest Developments
7.25 Enzo Biochem, Inc.
7.25.1 Enzo Biochem, Inc. Company Summary
7.25.2 Enzo Biochem, Inc. Business Overview
7.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Major Product Offerings
7.25.4 Enzo Biochem, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.25.5 Enzo Biochem, Inc. Key News & Latest Developments
7.26 Lonza Group
7.26.1 Lonza Group Company Summary
7.26.2 Lonza Group Business Overview
7.26.3 Lonza Group Immuno-oncology Drugs Major Product Offerings
7.26.4 Lonza Group Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.26.5 Lonza Group Key News & Latest Developments
7.27 Bio-Rad Laboratories, Inc.
7.27.1 Bio-Rad Laboratories, Inc. Company Summary
7.27.2 Bio-Rad Laboratories, Inc. Business Overview
7.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Major Product Offerings
7.27.4 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.27.5 Bio-Rad Laboratories, Inc. Key News & Latest Developments
7.28 Avantor, Inc.
7.28.1 Avantor, Inc. Company Summary
7.28.2 Avantor, Inc. Business Overview
7.28.3 Avantor, Inc. Immuno-oncology Drugs Major Product Offerings
7.28.4 Avantor, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.28.5 Avantor, Inc. Key News & Latest Developments
7.29 Spring Bank Pharmaceuticals, Inc.
7.29.1 Spring Bank Pharmaceuticals, Inc. Company Summary
7.29.2 Spring Bank Pharmaceuticals, Inc. Business Overview
7.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Major Product Offerings
7.29.4 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.29.5 Spring Bank Pharmaceuticals, Inc. Key News & Latest Developments
7.30 Ferring Pharmaceuticals
7.30.1 Ferring Pharmaceuticals Company Summary
7.30.2 Ferring Pharmaceuticals Business Overview
7.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Major Product Offerings
7.30.4 Ferring Pharmaceuticals Immuno-oncology Drugs Sales and Revenue in Global (2018-2023)
7.30.5 Ferring Pharmaceuticals Key News & Latest Developments
8 Global Immuno-oncology Drugs Production Capacity, Analysis
8.1 Global Immuno-oncology Drugs Production Capacity, 2018-2029
8.2 Immuno-oncology Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Immuno-oncology Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Immuno-oncology Drugs Supply Chain Analysis
10.1 Immuno-oncology Drugs Industry Value Chain
10.2 Immuno-oncology Drugs Upstream Market
10.3 Immuno-oncology Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immuno-oncology Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
